Abstract
healthy, their survival is given precedence over graft efficacy 62 [14] . The normal liver has a large functional reserve. Starzl 63 et al [15] reported that a minimum residual liver volume of 64 30% was required for patient survival. Similar results were 65 reported by Shindl et al [16] , where a residual liver volume 66 of less than 27% was associated with a marked increase in 67 the incidence of hepatic dysfunction. The ethical preference 68 for donor safety and a limit on the size of obtainable donor 69 liver mass explain why, with the exception of pediatric 70 patients, almost all partial liver grafts are suboptimal in size.
71
At the moment, the extended right liver graft technique 72 harvests the largest possible liver size (roughly 66% of the 73 donor liver) [17] . To obtain a graft of suitable size, ALDLT 74 often mandates the use of donor right hepatectomy. This 75 procedure has a donor safety profile much less favorable than 76 left hepatectomy, a large and potentially risky operation in its 77 own right. [18] . Donor morbidity and mortality are estimated 78 at 20% [19] and 0.5% [20] , respectively, which have been 79 confirmed by a recent series [21] . 80 3. Definition of the small-for-size graft 81 An accepted definition of the small-for-size graft has not 82 been established within the transplantation community.
83
There are currently 2 schools of thought.
84
Small-for-size liver grafts can be classified as those with 85 graft weight to estimated standard liver weight ratio of less 86 than 40% [22] [23] [24] . Grafts below the critical size are 87 associated with poor early graft function and a marked 88 reduction in graft and patient survival after transplantation 89 [13] . Alternatively, the definition of small-for-size liver 90 grafts can be extended to include all grafts smaller than the 91 standard liver volume (calculated using the formula by Urata 92 et al [25] ) [26] .
93
The former definition focuses on grafts with unacceptable 94 survival, whereas the latter classifies virtually all liver grafts 95 from living related donors as small-for-size [27] . Because of 96 the increasing evidence that size-related injury extends 97 beyond grafts less than 40% of the standard liver weight, the 98 latter definition is preferred because it represents a more 99 complete picture of the pathologic process. The cohort 100 described by the former will be referred to as marginal grafts. Small-for-size liver graft injury refers to the insult related 103 to the small size of the graft in addition to ischemia/ 104 reperfusion injury [27] ESLV. This threshold point is shared by Nishizaki et al [51] . 250 Lo et al [52] reported that graft sizes below 40% of ESLV Ben-Haim et al [53] [58] , and poor preoperative health status).
266
For small-for-size liver grafts with GRWR of more than (75% survival at 4 years) [61, 62] . In comparison, the tumor 319 recurrence rate after ALDLT remains controversial. there is increasing evidence that partial liver grafts lead to 326 higher tumor recurrence after ALDLT for HCC.
327
On one hand, Hwang et al [63] reported no significant 328 difference in the HCC recurrence rates between the 2 cohorts. leads to a decrease in hepatic arterial flow. In a study by Doi Fig. 3 . A, Liver tumor development after liver transplantation using whole or small-for-size liver grafts at day 14 and day 21. B, The liver occupied by tumor was compared at different time points. C, Liver tumor growth in nude mice at week 4 and week 6 after tumor implantation from group W or group S. D, The volume of tumors from nude mice was also compared. *P b .05 group W vs group S. (From Man et al., Ann Surg, in press Q3 ).
et al [66] , prolonged liver ischemia induced higher secretion 396 of inflammatory cytokines, increased free radical formation,
397
and subsequently increased liver metastasis of colon cancer.
398
van der Bilt et al [67] reported that ischemic lobes in murine ) [69] . It was found that acute phase small-for-size whose expression is in turn promoted by liver ischemia Fig. 4 . Possible mechanism of invasive tumor growth after transplantation using small-for-size grafts. [79] . 
